The global market for Endoscopic Submucosal Dissection was estimated at US$316.5 Million in 2025 and is projected to reach US$427.3 Million by 2032, growing at a CAGR of 4.4% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The advantages of organ preservation, reduced recurrence rates, and minimal post-procedural complications have led to growing adoption of ESD in gastroenterology. Additionally, the expansion of endoscopic training programs and AI-assisted tumor identification tools has improved the availability and success rates of ESD procedures worldwide. As oncologists and gastroenterologists seek more effective, minimally invasive cancer treatment options, demand for specialized ESD instruments and techniques is rising.
Additionally, robot-assisted endoscopic systems are being developed to improve precision and operator control during complex ESD procedures. AI-driven deep-learning algorithms integrated into endoscopic imaging platforms are enhancing early cancer detection and classification, ensuring better patient outcomes. The integration of virtual reality (VR)-based ESD training modules has also accelerated the skill development of gastroenterologists, expanding access to highly specialized ESD techniques globally.
Additionally, increasing investments in endoscopy training, AI-powered diagnostics, and robotic-assisted ESD systems have contributed to higher procedural success rates and improved patient recovery times. As healthcare providers continue to prioritize non-invasive, organ-sparing treatment modalities, the global adoption of ESD is expected to grow, reshaping early gastrointestinal cancer management and treatment paradigms.
Global Endoscopic Submucosal Dissection (ESD) Market - Key Trends & Drivers Summarized
How Is Endoscopic Submucosal Dissection Transforming Gastrointestinal Oncology?
Endoscopic Submucosal Dissection (ESD) is an advanced endoscopic technique used for en bloc resection of early-stage gastrointestinal cancers and precancerous lesions. ESD allows complete removal of tumors in the esophagus, stomach, and colon without requiring open surgery, making it a highly effective alternative to traditional surgical excision. This procedure has gained significant traction in the treatment of early gastric cancer, esophageal squamous cell carcinoma, and colorectal neoplasms, particularly in regions such as Japan, South Korea, and Europe, where screening programs have improved early cancer detection.The advantages of organ preservation, reduced recurrence rates, and minimal post-procedural complications have led to growing adoption of ESD in gastroenterology. Additionally, the expansion of endoscopic training programs and AI-assisted tumor identification tools has improved the availability and success rates of ESD procedures worldwide. As oncologists and gastroenterologists seek more effective, minimally invasive cancer treatment options, demand for specialized ESD instruments and techniques is rising.
What Are the Key Innovations in Endoscopic Submucosal Dissection?
The development of high-precision ESD knives, real-time endoscopic imaging, and AI-powered lesion detection algorithms has significantly improved the accuracy and safety of tumor resections. Electrosurgical ESD knives with water-jet-assisted dissection have enhanced submucosal tissue separation, reducing bleeding risks and improving en bloc resection rates.Additionally, robot-assisted endoscopic systems are being developed to improve precision and operator control during complex ESD procedures. AI-driven deep-learning algorithms integrated into endoscopic imaging platforms are enhancing early cancer detection and classification, ensuring better patient outcomes. The integration of virtual reality (VR)-based ESD training modules has also accelerated the skill development of gastroenterologists, expanding access to highly specialized ESD techniques globally.
What Is Driving the Growth of the Endoscopic Submucosal Dissection Market?
The growth in the ESD market is driven by rising gastrointestinal cancer incidence, increased adoption of minimally invasive tumor resection techniques, and advancements in AI-assisted endoscopic imaging. The expansion of cancer screening programs, particularly in high-risk regions, has improved early detection rates, increasing demand for ESD as a primary treatment option.Additionally, increasing investments in endoscopy training, AI-powered diagnostics, and robotic-assisted ESD systems have contributed to higher procedural success rates and improved patient recovery times. As healthcare providers continue to prioritize non-invasive, organ-sparing treatment modalities, the global adoption of ESD is expected to grow, reshaping early gastrointestinal cancer management and treatment paradigms.
Report Scope
The report analyzes the Endoscopic Submucosal Dissection market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:- Segments: Product Type (Gastroscopes & Colonoscopes, Knives, Injection Agents, Tissue Retractors, Graspers / Clips, Other Products); Indication (Stomach Cancer, Colon Cancer, Esophageal Cancer); End-Use (Hospitals, Outpatient Facilities).
- Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Gastroscopes & Colonoscopes segment, which is expected to reach US$103.7 Million by 2032 with a CAGR of 3.6%. The Knives segment is also set to grow at 4.9% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $97.9 Million in 2025, and China, forecasted to grow at an impressive 7.8% CAGR to reach $102.4 Million by 2032. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Endoscopic Submucosal Dissection Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Endoscopic Submucosal Dissection Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Endoscopic Submucosal Dissection Market expected to evolve by 2032?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2032?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2025 to 2032.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as Beijing ZKSK Technology Co., Ltd., Boston Scientific Corporation, CONMED Corporation, Cook Group, Cook Medical and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the companies featured in this Endoscopic Submucosal Dissection market report include:
- Beijing ZKSK Technology Co., Ltd.
- Boston Scientific Corporation
- CONMED Corporation
- Cook Group
- Cook Medical
- Creo Medical PLC
- DCC Healthcare
- Erbe Elektromedizin GmbH
- FUJIFILM Holdings Corporation
- Hangzhou AGS MedTech Co., Ltd.
- HOYA Corporation
- Innova Medica SPA
- Jiangsu Vedkang Medical Science and Technology Co., Ltd.
- KARL STORZ SE & Co. KG
- Kossen Co., Ltd.
- Leo Medical Co., Ltd.
- Medtronic PLC
- Micro-Tech Endoscopy
- MTW-Endoskopie W. Haag KG
- Olympus Corporation
Domain Expert Insights
This market report incorporates insights from domain experts across enterprise, industry, academia, and government sectors. These insights are consolidated from multilingual multimedia sources, including text, voice, and image-based content, to provide comprehensive market intelligence and strategic perspectives. As part of this research study, the publisher tracks and analyzes insights from 43 domain experts. Clients may request access to the network of experts monitored for this report, along with the online expert insights tracker.Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Beijing ZKSK Technology Co., Ltd.
- Boston Scientific Corporation
- CONMED Corporation
- Cook Group
- Cook Medical
- Creo Medical PLC
- DCC Healthcare
- Erbe Elektromedizin GmbH
- FUJIFILM Holdings Corporation
- Hangzhou AGS MedTech Co., Ltd.
- HOYA Corporation
- Innova Medica SPA
- Jiangsu Vedkang Medical Science and Technology Co., Ltd.
- KARL STORZ SE & Co. KG
- Kossen Co., Ltd.
- Leo Medical Co., Ltd.
- Medtronic PLC
- Micro-Tech Endoscopy
- MTW-Endoskopie W. Haag KG
- Olympus Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 386 |
| Published | June 2026 |
| Forecast Period | 2025 - 2032 |
| Estimated Market Value ( USD | $ 316.5 Million |
| Forecasted Market Value ( USD | $ 427.3 Million |
| Compound Annual Growth Rate | 4.4% |
| Regions Covered | Global |
